Paolo Mussone, Isabel Espinoza, Matthew Christensen, Elham Borujeni, Kyle Minor, Gordon Nish, Feng Wang, Valentyna Semenchenko and Carlo Montemagno.
Ingenuity Lab, 11421 Saskatchewan Drive, Edmonton, Alberta T6G 2M9, Canada
Department of Chemical and Materials Engineering, University of Alberta, Edmonton T6G 2V4, Canada
The repurposing of carbon dioxide (CO2) emissions is a key-element to transition current industrial processes toward an environmentally sustainable future. In this context, biocatalytic conversion of carbon dioxide has been the focus of considerable research and development investments over the past decade. However, major technological breakthroughs have been limited by the inherent inefficiencies associated with using whole cell biocatalysts.
This contribution highlights the CCEMC co-funded Ingenuity Lab’s artificial photosynthesis program, an integrated multi-disciplinary effort directed to overcoming the limitations of traditional biotechnology systems used for carbon dioxide transformation. By incorporating the metabolic processes responsible for carbon fixation in living organisms into an artificial continuous industrial process, Ingenuity Lab has engineered a novel technology platform to create value added chemicals by utilizing carbon dioxide as its principal feedstock.
This presentation will highlight the key-technological features of this platform and illustrate how these are assembled into a multi-scale engineered prototype. Ongoing research efforts focused on the design of an optimal nanoscale bioreactor architecture and progress toward scaling up the manufacturing of nanostructure for the regeneration of enzyme cofactors form the centerpieces of this contribution.